NLRP3 and COVID-19: When inhibited with MCC950, the virus was released by infected macrophages, which indicated that the NLRP3 gene is activated to prevent SARS-CoV-2 infection.258 Together, early treatment targeting NLRP3 inflammasome could improve the prognosis of COVID-19.